Imunon, Inc. Files 8-K: Other Events & Financials
Ticker: IMNN · Form: 8-K · Filed: Jul 28, 2025 · CIK: 749647
| Field | Detail |
|---|---|
| Company | Imunon, INC. (IMNN) |
| Form Type | 8-K |
| Filed Date | Jul 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, financials
TL;DR
Imunon filed an 8-K for 'Other Events' and financials on 7/28/25. Details TBD.
AI Summary
Imunon, Inc. filed an 8-K on July 28, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about the nature of these events or financial statements, only that they are being reported.
Why It Matters
This 8-K filing indicates that Imunon, Inc. is reporting significant events and financial updates, which could impact investors' understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and exhibits, with no immediate indication of negative news or significant financial distress.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- July 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-15911 (identifier) — Commission File Number
- 52-1256615 (identifier) — IRS Employer Identification No.
- 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311 (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Imunon, Inc. in this 8-K filing?
The filing states 'Other Events' as an item information but does not provide specific details about what these events entail.
What is the nature of the 'Financial Statements and Exhibits' being filed?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific content or nature of these documents is not detailed within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 28, 2025.
What is Imunon, Inc.'s state of incorporation and principal executive office address?
Imunon, Inc. is incorporated in Delaware and its principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311.
Does this filing mention any former company names or dates of name changes?
Yes, the filing mentions former company names including Celsion Corp (with name changes on 20071121 and 19980515) and Cheung Laboratories Inc (with a name change on 19920703).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 28, 2025 regarding Imunon, Inc. (IMNN).